Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 11/20 | 0.33 |
| ▸ | BCHE | P06276 | 3/20 | 0.33 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19759491 | 0.86 | EPHX1 (0.39) | EPHX2EPHX1 | |
| SCHEMBL19422674 | 0.81 | ACHE (0.47) | EPHX2ACHEBCHEGAAEPHX1 | |
| SCHEMBL17884347 | 0.77 | TSHR (0.40) | EPHX2ACHEGAA | |
| SCHEMBL6300796 | 0.77 | DRD2 (0.32) | SGPL1GAA | |
| SCHEMBL8944642 | 0.75 | EPHX2 (0.36) | EPHX2ACHEGAAEPHX1 | |
| SCHEMBL17883538 | 0.74 | EPHX1 (0.45) | EPHX2ACHEGAAEPHX1 | |
| SCHEMBL185586 | 0.73 | EPHX2 (0.39) | EPHX2ACHEEPHX1 | |
| SCHEMBL22699687 | 0.73 | EPHX2 (0.39) | EPHX2ACHEEPHX1 | |
| SCHEMBL28647242 | 0.73 | EPHX2 (0.39) | EPHX2ACHEEPHX1 | |
| SCHEMBL12047216 | 0.73 | EPHX2 (0.39) | EPHX2ACHEEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180002285-A1 | STERICALLY HINDERED ALKYL AND OXYALKYL AMINE LIGHT STABILIZERS | 3M INNOVATIVE PROPERTIES COMPANY | 2018-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180002285-A1 | STERICALLY HINDERED ALKYL AND OXYALKYL AMINE LIGHT STABILIZERS | AAAS, MAP1LC3A, ACTL6A | EPHX2 3108/4885ACHE 3850/4885BCHE 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.